News und Analysen
EQS-News: Half-year results: PNE AG reports operational success in H1
Applied Therapeutics Reports Q2 Loss
Applied Therapeutics (NASDAQ:APLT), a biotechnology company focused on developing treatments for rare metabolic diseases, reported earnings results for Q2 2025 on August 13, 2025. The main news from
Ibotta Posts 2 Percent Sales Decline
Ibotta (NYSE:IBTA), a leading digital promotions and performance marketing platform for consumer packaged goods (CPG), released financial results for Q2 2025 on August 13, 2025. The most notable
Natural Gas Services Group Beats Q2 EPS
Natural Gas Services Group (NYSE:NGS), a provider of natural gas compression equipment rentals and services, Natural Gas Services Group released its financial results for Q2 FY2025 on August 11
Acrivon Posts Narrower Loss in Q2
Acrivon Therapeutics (NASDAQ:ACRV), a clinical-stage biotech developing precision oncology medicines, released its second quarter 2025 results on August 13, 2025. The report showed a GAAP net loss
Tenax Posts Wider Loss in Fiscal Q2
Tenax Therapeutics (NASDAQ:TENX), a development-stage biopharmaceutical company focused on treatments for cardiovascular and pulmonary diseases, released its results for the second quarter of fiscal
Fossil Posts Narrower Loss in Q2
Fossil Group (NASDAQ:FOSL), known for its portfolio of fashion watches and accessories, reported its latest quarterly results on Aug. 13, 2025. The most notable news in the release was a
Alto Neuroscience Posts Q2 Net Loss
Alto Neuroscience (NYSE:ANRO), a clinical-stage biotechnology company focused on precision psychiatry, released its second-quarter results on August 13, 2025. It reported a net loss of $17.7
Red Robin Swings to Profit in Fiscal Q2
Red Robin Gourmet Burgers (NASDAQ:RRGB), a family-friendly, casual-dining chain known for gourmet burgers and bottomless sides, released its fiscal second quarter 2025 results on August 13, 2025
Jade Biosciences Posts Wider Loss in Q2
Jade Biosciences (NASDAQ:JBIO), a biotechnology company focused on autoimmune disease therapies, published its results on August 13, 2025. The standout message: the company reported a GAAP net loss
Barfresh Reports 11% Revenue Gain in Q2
Barfresh Food Group (NASDAQ:BRFH), a provider of ready-to-drink and frozen beverage products often found in schools and institutional settings, released earnings for the second quarter of fiscal
Lumentum Q4 Revenue and Margins Surge
Lumentum(NASDAQ:LITE) reported fourth quarter fiscal 2025 results on August 12, 2025, with non-GAAP revenue of $480.7 million and non-GAAP EPS of $0.88, both exceeding the high end of guidance. The
Spectral Ai Posts 32% Revenue Drop in Q2
Spectral Ai (NASDAQ:MDAI), a medical technology company specializing in wound care diagnostics, reported its second quarter 2025 results on August 13, 2025. The big news of the release was the
Intellinetics Sales Down 13.6 Percent
Intellinetics (NYSEMKT:INLX), a provider of document management and digital transformation software, released its results on August 13, 2025. The most notable developments were a
Kodiak Sciences Beats Q2 Loss Estimates
Kodiak Sciences (NASDAQ:KOD), a biotechnology company specializing in retinal disease therapies, released its Q2 2025 earnings results on August 13, 2025. The most notable news: the company reported
SKYX Platforms Revenue Jumps 8% in Q2
SKYX Platforms (NASDAQ:SKYX), a developer of advanced smart-home and safety platform technologies, released its earnings for the second quarter of fiscal 2025 on August 12, 2025. Gross profit (GAAP)
Urban One Reports 22% Revenue Drop in Q2
Urban One (NASDAQ:UONE), a media company focused on serving African-American and urban audiences, reported Q2 fiscal 2025 results on August 13, 2025. The report highlighted a significant
Lumentum Revenue Jumps 56 Percent in Q4
Lumentum (NASDAQ:LITE), a maker of optical and photonic components for cloud, networking, and industrial applications, released its fiscal fourth-quarter results on August 12, 2025. The key news
Ieh Posts 11 Percent Revenue Drop in Q1
IEH (OTC:IEHC), a specialty electronic connector manufacturer serving the military, aerospace, and industrial markets, reported first quarter fiscal 2026 results on August 13, 2025. The report
Arcos Dorados Sales Reach $1.1 Billion
Arcos Dorados(NYSE:ARCO) reported second quarter 2025 results on August 13, 2025. Total revenue reached $1.1 billion, with systemwide comparable sales up 12.1% and adjusted EBITDA at $110.1 million
ProPhase Labs Posts Narrower Q2 Loss
ProPhase Labs (NASDAQ:PRPH), a diversified consumer healthcare and diagnostics company, posted its second-quarter 2025 results on August 13, 2025. The most notable news was a sharp shortfall in GAAP
Connect Biopharma Posts Q2 Revenue Drop
Connect Biopharma (NASDAQ:CNTB), a biotechnology company developing therapies for inflammatory diseases, released its second quarter 2025 earnings on August 13, 2025. The main highlight was a
Loar Posts 27 Percent Revenue Jump in Q2
Loar (NYSE:LOAR), an aerospace and defense supplier known for its proprietary components and strong aftermarket presence, released its second quarter earnings on August 13, 2025. The standout news
Moleculin Biotech Misses Fiscal Q2 EPS
Moleculin Biotech (NASDAQ:MBRX), a clinical-stage pharmaceutical developer focused on oncology, released its second quarter 2025 results on August 13, 2025.
The biggest news from this update was a
VerifyMe Beats Q2 Loss Revenue Drops 16%
VerifyMe (NASDAQ:VRME), a provider of logistics technology and authentication solutions for high-value and sensitive shipments, reported second quarter results on August 13, 2025. The company posted